(Q38860839)

7 September 2017

1 reference

title

Restoring regulation - IL-2 therapy in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

7 September 2017

0 references

2

Gabriela Riemekasten

1 reference

7 September 2017

Jens Y Humrich

1

1 reference

7 September 2017

9 June 2016

1 reference

Expert Review of Clinical Immunology

7 September 2017

1 reference

7 September 2017

12

1 reference

7 September 2017

11

1 reference

7 September 2017

1153-1160

1 reference

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

7 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Structure of the human interleukin 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Structure and expression of a cloned cDNA for human interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

The biology of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin-2 receptor signaling: at the interface between tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

A function for interleukin 2 in Foxp3-expressing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

The role of the transcription factor Foxp3 in the development of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

[Regulatory T cells and rheumatic diseases].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Regulatory T cells in human disease and their potential for therapeutic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Human T regulatory cell therapy: take a billion or so and call me in the morning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

How do CD4+CD25+ regulatory T cells control autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

TREG-cell therapies for autoimmune rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

IL-2, regulatory T cells, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Antisense cyclic adenosine 5'-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Transcriptional repression of interleukin-2 in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

cAMP responsive element modulator: a critical regulator of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin-2 and regulatory T cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin-2 and systemic lupus erythematosus--fifteen years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

IL-2 therapy in type 1 diabetes: "Trials" and tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Interleukin 2 in the pathogenesis and therapy of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1199957

10.1080/1744666X.2016.1199957

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

27283871